Coronavirus
Coronavirus
Sally Pipes Talks COVID-19 Remdisivir Treatment on Alabama Morning News
Sally C. Pipes joined JT Nysewamder on Alabama Morning News in Birmingham to talk about the latest developments with the drug remdisivir. The drug, produced by Gilead, is being studied for potential use against COVID-19. Pipes and JT also discuss the cost of the drug, and how expensive it is ...
Business & Economics
A Better Alternative to More Coronavirus Stimulus Spending and Loan Programs
By Rod Richardson and Wayne Winegarden As the nation grapples with the ongoing coronavirus pandemic, the U.S. Senate may soon consider another federal stimulus package. Some politicians favor trillions in additional federal spending and lending, but before we further explode the debt and deficit, let’s pause and think about what ...
Commentary
We know how to safely reopen the country
More than eight in 10 Americans fear a second wave of the coronavirus outbreak, according to recent polling from Ipsos. Some cities and states have halted efforts to reopen their economies, in response to rising case counts. But there’s no reason to be fearful. We now have enough information about the coronavirus and ...
Commentary
Will COVID-19 launch an epidemic of cancer?
With coronavirus cases spiking, Texas Gov. Greg Abbott has issued an order halting the state’s reopening and banning elective procedures in hot-spot counties. As more states see viral outbreaks, many governors will be tempted to follow Gov. Abbott’s example. But COVID-19 is not the only threat to public health. Millions ...
Coronavirus
Dr. Henry Miller and Lars Larson Talk COVID Surge and PPE
Dr. Henry Miller joins the nationally-syndicated Lars Larson Show to talk about the latest changes in the coronavirus, or COVID-19, including the developments in the American southwest including steps the public can take to stop the spread of coronavirus and the dwindling number of hospital beds. Miller talks about why ...
Coronavirus
Dr. Henry Miller and John Batchelor Review FDA COVID-19 Guidelines
PRI’s Dr. Henry Miller joins the John Batchelor Show to review the latest developments with the vaccine guidelines and the FDA. The FDA testified before Congress that they will have complicated guidelines for a potential COVID-19 vaccine. Miller mentioned that the FDA guidelines are reassuring as it indicates that future ...
Commentary
Coronavirus drug cost – Ignore critics. Here’s why the price is right
Last week, Gilead Sciences announced that it would sell a five-day course of its coronavirus drug, remdesivir, for just over $3,100. The antiviral, currently the only medication proven to speed recovery from COVID-19, received FDA approval in May. Some Democratic lawmakers and policy experts attacked remdesivir’s price as soon as it was announced. They claim that Gilead could sell the drug ...
Commentary
Democrats Remain Jealous Of Britain’s Healthcare Catastrophe
If there was ever any doubt about the dangers of single-payer health care, the United Kingdom’s experience with COVID-19 should settle the matter. Weeks after the pandemic’s peak, the nation’s government-run health system, the National Health Service, is still subjecting patients to life-threatening treatment delays. By the NHS’s own admission, ...
Commentary
We must relax restrictions on foreign doctors
The Trump administration just made it a bit easier for foreign doctors to join the fight against the coronavirus. This month, U.S. Citizenship and Immigration Services authorized foreign doctors in the Conrad 30 program to conduct telehealth visits across state lines. Previously, these doctors — up to 30 per state ...
Commentary
Learning The Right Lessons From The Race For An Effective Covid-19 Treatment
On June 29, 2020 Gilead announced its price for remdesivir – an antiviral medication that has shown efficacy shortening the recovery time for patients with Covid-19. This price announcement provides several important lessons for the U.S. healthcare system. First, and perhaps most important, innovation is essential for winning the war against Covid-19. ...
Sally Pipes Talks COVID-19 Remdisivir Treatment on Alabama Morning News
Sally C. Pipes joined JT Nysewamder on Alabama Morning News in Birmingham to talk about the latest developments with the drug remdisivir. The drug, produced by Gilead, is being studied for potential use against COVID-19. Pipes and JT also discuss the cost of the drug, and how expensive it is ...
A Better Alternative to More Coronavirus Stimulus Spending and Loan Programs
By Rod Richardson and Wayne Winegarden As the nation grapples with the ongoing coronavirus pandemic, the U.S. Senate may soon consider another federal stimulus package. Some politicians favor trillions in additional federal spending and lending, but before we further explode the debt and deficit, let’s pause and think about what ...
We know how to safely reopen the country
More than eight in 10 Americans fear a second wave of the coronavirus outbreak, according to recent polling from Ipsos. Some cities and states have halted efforts to reopen their economies, in response to rising case counts. But there’s no reason to be fearful. We now have enough information about the coronavirus and ...
Will COVID-19 launch an epidemic of cancer?
With coronavirus cases spiking, Texas Gov. Greg Abbott has issued an order halting the state’s reopening and banning elective procedures in hot-spot counties. As more states see viral outbreaks, many governors will be tempted to follow Gov. Abbott’s example. But COVID-19 is not the only threat to public health. Millions ...
Dr. Henry Miller and Lars Larson Talk COVID Surge and PPE
Dr. Henry Miller joins the nationally-syndicated Lars Larson Show to talk about the latest changes in the coronavirus, or COVID-19, including the developments in the American southwest including steps the public can take to stop the spread of coronavirus and the dwindling number of hospital beds. Miller talks about why ...
Dr. Henry Miller and John Batchelor Review FDA COVID-19 Guidelines
PRI’s Dr. Henry Miller joins the John Batchelor Show to review the latest developments with the vaccine guidelines and the FDA. The FDA testified before Congress that they will have complicated guidelines for a potential COVID-19 vaccine. Miller mentioned that the FDA guidelines are reassuring as it indicates that future ...
Coronavirus drug cost – Ignore critics. Here’s why the price is right
Last week, Gilead Sciences announced that it would sell a five-day course of its coronavirus drug, remdesivir, for just over $3,100. The antiviral, currently the only medication proven to speed recovery from COVID-19, received FDA approval in May. Some Democratic lawmakers and policy experts attacked remdesivir’s price as soon as it was announced. They claim that Gilead could sell the drug ...
Democrats Remain Jealous Of Britain’s Healthcare Catastrophe
If there was ever any doubt about the dangers of single-payer health care, the United Kingdom’s experience with COVID-19 should settle the matter. Weeks after the pandemic’s peak, the nation’s government-run health system, the National Health Service, is still subjecting patients to life-threatening treatment delays. By the NHS’s own admission, ...
We must relax restrictions on foreign doctors
The Trump administration just made it a bit easier for foreign doctors to join the fight against the coronavirus. This month, U.S. Citizenship and Immigration Services authorized foreign doctors in the Conrad 30 program to conduct telehealth visits across state lines. Previously, these doctors — up to 30 per state ...
Learning The Right Lessons From The Race For An Effective Covid-19 Treatment
On June 29, 2020 Gilead announced its price for remdesivir – an antiviral medication that has shown efficacy shortening the recovery time for patients with Covid-19. This price announcement provides several important lessons for the U.S. healthcare system. First, and perhaps most important, innovation is essential for winning the war against Covid-19. ...
